{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:15:31Z","timestamp":1792451731298,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.ymgme.2008.01.013","type":"journal-article","created":{"date-parts":[[2008,3,19]],"date-time":"2008-03-19T01:50:57Z","timestamp":1205891457000},"page":"190-203","source":"Crossref","is-referenced-by-count":43,"title":["Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid \u03b2-glucosidase residual activity levels"],"prefix":"10.1016","volume":"94","author":[{"given":"You-Hai","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Reboulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Huelsken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2008.01.013_bib1","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ymgme.2008.01.013_bib2","first-page":"176","article-title":"Infantile Gaucher\u2019s disease: electron microscopic and histochemical studies of a cerebral biopsy","volume":"26","author":"Volk","year":"1967","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymgme.2008.01.013_bib3","first-page":"513","article-title":"Fine structure of central nervous system in early infantile Gaucher\u2019s disease","volume":"83","author":"Adachi","year":"1967","journal-title":"Arch. Pathol."},{"key":"10.1016\/j.ymgme.2008.01.013_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1067\/S0022-3476(03)00302-0","article-title":"Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3","volume":"143","author":"Goker-Alpan","year":"2003","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2008.01.013_bib5","first-page":"41","article-title":"Myoclonus in Gaucher disease","volume":"89","author":"Frei","year":"2002","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.ymgme.2008.01.013_bib6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2008.01.013_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/14734220410035356","article-title":"Progressive myoclonic epilepsy","volume":"3","author":"Zupanc","year":"2004","journal-title":"Cerebellum"},{"key":"10.1016\/j.ymgme.2008.01.013_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1203\/00006450-198305000-00007","article-title":"Biochemical studies in a patient with subacute neuropathic Gaucher disease without visceral glucosylceramide storage","volume":"17","author":"Wenger","year":"1983","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2008.01.013_bib9","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"3635","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.ymgme.2008.01.013_bib10","series-title":"The Metabolic and Molecular Bases of Inherited Disease","article-title":"Gaucher disease: phenotypic and genetic variation","author":"Grabowski","year":"2005"},{"key":"10.1016\/j.ymgme.2008.01.013_bib11","first-page":"231","article-title":"Chemical differentiation of the Gaucher subtypes","volume":"95","author":"Svennerholm","year":"1982","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.ymgme.2008.01.013_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00690463","article-title":"Neuropathology of the Norrbottnian type of Gaucher disease. Morphological and biochemical studies","volume":"65","author":"Conradi","year":"1984","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.ymgme.2008.01.013_bib13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/357407a0","article-title":"Animal model of Gaucher\u2019s disease from targeted disruption of the mouse glucocerebrosidase gene","volume":"357","author":"Tybulewicz","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2008.01.013_bib14","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1073\/pnas.95.5.2503","article-title":"Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure","volume":"95","author":"Liu","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.01.013_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0006-291X(75)90286-7","article-title":"The Gaucher mouse","volume":"67","author":"Kanfer","year":"1975","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2008.01.013_bib16","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid \u03b2-glucosidase deficiency: the defect in Gaucher disease","volume":"163","author":"Xu","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2008.01.013_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/(SICI)1096-8628(20000320)91:3<222::AID-AJMG13>3.0.CO;2-#","article-title":"Severe type II Gaucher disease with ichthyosis arthrogryposis and neuronal apoptosis: molecular and pathological analyses","volume":"91","author":"Finn","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2008.01.013_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/jmg.33.2.132","article-title":"The clinical, molecular, and pathological characterisation of a family with two cases of lethal perinatal type 2 Gaucher disease","volume":"33","author":"Sidransky","year":"1996","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2008.01.013_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/(SICI)1096-8628(19971128)73:1<41::AID-AJMG9>3.0.CO;2-S","article-title":"Prenatal lethality of a homozygous null mutation in the human glucocerebrosidase gene","volume":"73","author":"Tayebi","year":"1997","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2008.01.013_bib20","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1471-4159.1976.tb05159.x","article-title":"Hydrolytic and transglucolytic activities of a partially purified calf brain beta-glucosidase","volume":"27","author":"Mumford","year":"1976","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2008.01.013_bib21","doi-asserted-by":"crossref","first-page":"23815","DOI":"10.1074\/jbc.M502799200","article-title":"X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide. Implications for Gaucher disease","volume":"280","author":"Premkumar","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.01.013_bib22","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/S0021-9258(17)42166-1","article-title":"Analysis of human acid beta-glucosidase by site-directed mutagenesis and heterologous expression","volume":"269","author":"Grace","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.01.013_bib23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0092-8674(01)00336-1","article-title":"Beta-catenin controls hair follicle morphogenesis and stem cell differentiation in the skin","volume":"105","author":"Huelsken","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2008.01.013_bib24","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1016\/S0021-9258(19)83905-4","article-title":"Human acid beta-glucosidase. Use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes","volume":"261","author":"Grabowski","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.01.013_bib25","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/0006-291X(83)91053-7","article-title":"Abnormal accumulation of galactosylceramide in the kidney of twitcher mouse","volume":"110","author":"Igisu","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2008.01.013_bib26","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1074\/jbc.M511110200","article-title":"Analyses of variant acid beta-glucosidases: effects of Gaucher disease mutations","volume":"281","author":"Liou","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.01.013_bib27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/archneur.1982.00510210020005","article-title":"Brain glucocerebrosidase in Gaucher\u2019s disease","volume":"39","author":"Daniels","year":"1982","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2008.01.013_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0304-4165(79)90134-X","article-title":"Enzymic effects of beta-glucosidase destruction in mice. Changes in glucuronidase levels","volume":"582","author":"Hara","year":"1979","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2008.01.013_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1242\/dev.116.1.201","article-title":"NeuN, a neuronal specific nuclear protein in vertebrates","volume":"116","author":"Mullen","year":"1992","journal-title":"Development"},{"key":"10.1016\/j.ymgme.2008.01.013_bib30","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1177\/44.10.8813082","article-title":"NeuN: a useful neuronal marker for diagnostic histopathology","volume":"44","author":"Wolf","year":"1996","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.ymgme.2008.01.013_bib31","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM197411072911901","article-title":"Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher\u2019s disease","volume":"291","author":"Brady","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2008.01.013_bib32","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1098\/rstb.2003.1278","article-title":"Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disorders","volume":"358","author":"Butters","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ymgme.2008.01.013_bib33","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/sj.gt.3302092","article-title":"Gene therapy progress and prospects: gene therapy of lysosomal storage disorders","volume":"10","author":"Cheng","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2008.01.013_bib34","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher\u2019s disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2008.01.013_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources","volume":"122","author":"Grabowski","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ymgme.2008.01.013_bib36","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1073\/pnas.2536657100","article-title":"Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis","volume":"100","author":"Matsuda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.01.013_bib37","doi-asserted-by":"crossref","first-page":"12075","DOI":"10.1073\/pnas.92.26.12075","article-title":"Selection of transduced CD34+ progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors","volume":"92","author":"Migita","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.01.013_bib38","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.01.013_bib39","series-title":"Gaucher Disease","first-page":"321","article-title":"Epidemiology and screening policy","author":"Meikle","year":"2007"},{"key":"10.1016\/j.ymgme.2008.01.013_bib40","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1517\/13543784.11.6.851","article-title":"Agalsidase alfa\u2014a preparation for enzyme replacement therapy in Anderson\u2013Fabry disease","volume":"11","author":"Beck","year":"2002","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ymgme.2008.01.013_bib41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpeds.2003.10.067","article-title":"Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations","volume":"144","author":"Charrow","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2008.01.013_bib42","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","article-title":"Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux\u2013Lamy syndrome)","volume":"144","author":"Harmatz","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2008.01.013_bib43","doi-asserted-by":"crossref","first-page":"347","DOI":"10.12968\/hosp.2002.63.6.2005","article-title":"Agalsidase alfa: specific treatment for Fabry disease","volume":"63","author":"Mehta","year":"2002","journal-title":"Hosp. Med."},{"key":"10.1016\/j.ymgme.2008.01.013_bib44","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1096\/fj.00-0014com","article-title":"Infusion of recombinant human acid sphingomyelinase into niemann\u2013pick disease mice leads to visceral, but not neurological, correction of the pathophysiology","volume":"14","author":"Miranda","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2008.01.013_bib45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1651-2227.2002.tb03118.x","article-title":"Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report","volume":"91","author":"Muenzer","year":"2002","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.ymgme.2008.01.013_bib46","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk","volume":"113","author":"Van den Hout","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2008.01.013_bib47","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mpd.2001.112171","article-title":"The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher\u2019s disease","volume":"138","author":"Altarescu","year":"2001","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2008.01.013_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/bcmd.2001.0477","article-title":"Early-onset severe neurological involvement and D409H homozygosity in Gaucher disease: outcome of enzyme replacement therapy","volume":"28","author":"Michelakakis","year":"2002","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2008.01.013_bib49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1096-8628(19970711)71:1<16::AID-AJMG3>3.0.CO;2-O","article-title":"Gaucher disease: enzyme therapy in the acute neuronopathic variant","volume":"71","author":"Prows","year":"1997","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2008.01.013_bib50","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2141.1993.tb03224.x","article-title":"Low-dose high-frequency enzyme replacement therapy for very young children with severe Gaucher disease","volume":"85","author":"Zimran","year":"1993","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgme.2008.01.013_bib51","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1022578424693","article-title":"Delivery, distribution, and neuronal uptake of exogenous mannose-terminal glucocerebrosidase in the intact rat brain","volume":"24","author":"Zirzow","year":"1999","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymgme.2008.01.013_bib52","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2006.09.008","article-title":"Generation of a conditional knockout of murine glucocerebrosidase: utility for the study of Gaucher disease","volume":"90","author":"Sinclair","year":"2007","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719208000164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719208000164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,5]],"date-time":"2021-09-05T23:43:45Z","timestamp":1630885425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719208000164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S1096719208000164"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2008.01.013","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}